Key statistics
As of last trade Brainstorm Cell Therapeutics Inc (GHD:FRA) traded at 0.1792, 0.00% above its 52-week low of 0.1792, set on Sep 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | 0.1792 |
Low | 0.1792 |
Bid | -- |
Offer | -- |
Previous close | 2.69 |
Average volume | -- |
---|---|
Shares outstanding | 5.32m |
Free float | 4.84m |
P/E (TTM) | -- |
Market cap | 6.64m USD |
EPS (TTM) | -3.46 USD |
Data delayed at least 15 minutes, as of Sep 30 2024 08:21 BST.
More ▼
Press releases
- BrainStorm Cell Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update
- BrainStorm Cell Therapeutics and Pluri Partner to Support NurOwn® Phase 3b Trial Manufacturing
- BrainStorm Cell Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
- BrainStorm Cell Therapeutics Presented Positive Survival Data from NurOwn® Expanded Access Program at 2024 Annual NEALS Meeting
- BrainStorm Cell Therapeutics to Provide Corporate Update on Phase 3b NurOwn® Trial at the 2024 Maxim Healthcare Virtual Summit
- BrainStorm Cell Therapeutics Announces Presentations on NurOwn® at 2024 Annual NEALS Meeting
More ▼